Role of the androgen, estrogen, and progesterone receptors in adherent perinephric fat in robotic partial nephrectomy

Autor: Alethea Paradis, Barrett G. Anderson, Eric H. Kim, Joel Vetter, R. Sherburne Figenshau, Jalal B. Jalaly, Aaron M. Potretzke, Justin Benabdallah, Kefu Du, Joshua Palka, Christopher Han, Rehan Rais, Ramakrishna Venkatesh
Rok vydání: 2021
Předmět:
Zdroj: Journal of Robotic Surgery. 16:143-148
ISSN: 1863-2491
1863-2483
DOI: 10.1007/s11701-021-01225-4
Popis: To determine whether androgen, estrogen, and/or progesterone signaling play a role in the pathophysiology of adherent perinephric fat (APF). We prospectively recruited patients undergoing robotic assisted partial nephrectomy during 2015–2017. The operating surgeon documented the presence or absence of APF. For those with clear cell renal cell carcinoma (ccRCC), representative sections of tumor and perinephric fat were immunohistochemically stained with monoclonal antibody to estrogen α, progesterone, and androgen receptors. Patient characteristics, operative data, and hormone receptor presence were compared between those with and without APF. Of 51 patients total, 18 (35.3%) and 33 (64.7%) patients did and did not have APF, respectively. APF was associated with history of diabetes mellitus (61.1% vs 24.2%, p = 0.009) and larger tumors (4.0 cm vs 3.0 cm, p = 0.017) but not with age, gender, BMI, Charleston comorbidity index, smoking, or preoperative estimated glomerular filtration rate. APF was not significantly associated with length of operation, positive margins, or 30-day postoperative complications but incurred higher estimated blood loss (236.5 mL vs 209.2 mL, p = 0.049). Thirty-two had ccRCC and completed hormone receptor staining. The majority of tumors and perinephric fat were negative for estrogen and progesterone while positive for androgen receptor expression. There was no difference in hormone receptor expression in either tumor or perinephric fat when classified by presence or absence of APF (p > 0.05). APF is more commonly present in patients with diabetes or larger tumors but was not associated with differential sex hormone receptor expression in ccRCC.
Databáze: OpenAIRE
Externí odkaz: